LENZ – lenz therapeutics, inc. (US:NASDAQ)
Stock Stats
News
LENZ Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Recent Corporate Highlights on March 24, 2026
LENZ Therapeutics (LENZ) had its "outperform" rating reaffirmed by William Blair.
LENZ Therapeutics Announces Submission of Marketing Authorization Application to European Medicines Agency for VIZZ® for the Treatment of Presbyopia
LENZ Therapeutics (LENZ) was upgraded by Wall Street Zen from "sell"
LENZ Therapeutics to Present at Upcoming Investor Conferences [Yahoo! Finance]
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: Ridgeback Capital Investments L.P.
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: FMR LLC
Form SCHEDULE 13G/A LENZ Therapeutics, Inc. Filed by: BlackRock, Inc.
Form 8-K LENZ Therapeutics, Inc. For: Jan 07
Form 4 LENZ Therapeutics, Inc. For: Jan 02 Filed by: Schimmelpennink Evert B.
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.